OrphAI Therapeutics Inc.

Industry

  • Digital Health
    • Artificial Intelligence
  • Pharmaceuticals
  • Biotechnology

Other Names/Subsidiaries

  • LAM Therapeutics
  • AI Therapeutics, Inc.
See more in Biomedtracker

Latest on OrphAI Therapeutics Inc.

Scrip

Deal Watch: Dragonfly Adds Gilead To Its List Of Big-Name Partners

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets 5T4-Targeted NK Cell Therap

Scrip

Finance Watch: Second Quarter Begins With Solid Base For Biopharma VC, Shaky Ground For Acorda

 
• By Mandy Jackson

Venture capital investors put $2.2bn into 128 biopharmaceutical companies in the first quarter of this year and at the rate that VC firms are raising new funds, 2017 could be another big financing yea

Scrip

Venture Funding Deals: LAM Nabs $58m Series C One Year After $40m Round

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bio

Scrip

Venture Funding Deals, March 2016

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Steven Muntner, and Maureen Riordan

IN VITRO DIAGNOSTICS BioDirection Inc. BioDirection completes $4mm Series B round BioDirection Inc. (brain injury diagnostics) completed a $4mm Series B convertible preferred stock sale to Pro